150 related articles for article (PubMed ID: 25590418)
1. In vitro aggregation assays using hyperphosphorylated tau protein.
Sui D; Liu M; Kuo MH
J Vis Exp; 2015 Jan; (95):e51537. PubMed ID: 25590418
[TBL] [Abstract][Full Text] [Related]
2. Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions.
Liu M; Dexheimer T; Sui D; Hovde S; Deng X; Kwok R; Bochar DA; Kuo MH
Sci Rep; 2020 Oct; 10(1):16551. PubMed ID: 33024171
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Tau Pathology in Alzheimer's Disease by Dietary Bioactive Compounds.
Shi H; Zhao Y
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255905
[TBL] [Abstract][Full Text] [Related]
4. How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?
Xu L; Zheng J; Margittai M; Nussinov R; Ma B
ACS Chem Neurosci; 2016 May; 7(5):565-75. PubMed ID: 26854860
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation.
Zhong H; Liu H; Liu H
Curr Med Chem; 2024; 31(20):2855-2871. PubMed ID: 37031392
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase G phosphorylates the Alzheimer's disease-associated tau protein at distinct Ser/Thr sites.
Montalto G; Caudano F; Sturla L; Bruzzone S; Salis A; Damonte G; Prickaerts J; Fedele E; Ricciarelli R
Biofactors; 2021 Jan; 47(1):126-134. PubMed ID: 33469985
[TBL] [Abstract][Full Text] [Related]
7. Single-Molecule Characterization and Super-Resolution Imaging of Alzheimer's Disease-Relevant Tau Aggregates in Human Samples.
Böken D; Cox D; Burke M; Lam JYL; Katsinelos T; Danial JSH; Fertan E; McEwan WA; Rowe JB; Klenerman D
Angew Chem Int Ed Engl; 2024 May; 63(21):e202317756. PubMed ID: 38523073
[TBL] [Abstract][Full Text] [Related]
8. Cellular polyamines condense hyperphosphorylated Tau, triggering Alzheimer's disease.
Ivanov SM; Atanasova M; Dimitrov I; Doytchinova IA
Sci Rep; 2020 Jun; 10(1):10098. PubMed ID: 32572101
[TBL] [Abstract][Full Text] [Related]
9. Anti-fibrillization effects of sulfonamide derivatives on
Fortin JS; Shimanaka K; Saraswati AP; Liu M; Wang KW; Hagar HT; Maity S; Ganegamage SK; Ellsworth E; Counts SE; Borhan B; Dettmer U; Kuo MH
J Mol Struct; 2022 Nov; 1267():. PubMed ID: 36310922
[TBL] [Abstract][Full Text] [Related]
10. Effects of heterologous human tau protein expression in yeast models of proteotoxic stress response.
Zubčić K; Franić D; Pravica M; Hof PR; Šimić G; Boban M
CNS Neurosci Ther; 2024 Jun; 30(6):e14304. PubMed ID: 37341072
[TBL] [Abstract][Full Text] [Related]
11. A Missing Origin of the Tau Protein Aggregation Pathway Triggered by Thermal and Biological Forces.
Lu HP
J Integr Neurosci; 2023 Oct; 22(6):145. PubMed ID: 38176940
[TBL] [Abstract][Full Text] [Related]
12. Sedimentation and Laser Light Scattering Methods for Quantifying Synthetic Tau Aggregation Propensity.
Malyshka D; Jimenez-Harrison D; Kuret J
Methods Mol Biol; 2024; 2754():117-129. PubMed ID: 38512664
[TBL] [Abstract][Full Text] [Related]
13. Yeast as a model system to study tau biology.
De Vos A; Anandhakumar J; Van den Brande J; Verduyckt M; Franssens V; Winderickx J; Swinnen E
Int J Alzheimers Dis; 2011 Apr; 2011():428970. PubMed ID: 21559193
[TBL] [Abstract][Full Text] [Related]
14. NDUFA12L mitochondrial complex-I assembly factor: Implications for taupathies.
Salama M; Mohamed WM
Appl Transl Genom; 2015 Jun; 5():37-9. PubMed ID: 26937358
[TBL] [Abstract][Full Text] [Related]
15. Tau aggregation following subcortical hemorrhage.
Jaeger E; Bischof GN; Onur OA; Schlamann M; Drzezga A
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2515-2516. PubMed ID: 38433149
[No Abstract] [Full Text] [Related]
16. Cellular factors modulating the mechanism of tau protein aggregation.
Fontaine SN; Sabbagh JJ; Baker J; Martinez-Licha CR; Darling A; Dickey CA
Cell Mol Life Sci; 2015 May; 72(10):1863-79. PubMed ID: 25666877
[TBL] [Abstract][Full Text] [Related]
17. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
Thal DR; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
[No Abstract] [Full Text] [Related]
18. Accelerating Alzheimer's research through 'natural' animal models.
Braidy N; Poljak A; Jayasena T; Mansour H; Inestrosa NC; Sachdev PS
Curr Opin Psychiatry; 2015 Mar; 28(2):155-64. PubMed ID: 25602247
[TBL] [Abstract][Full Text] [Related]
19. Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats.
Stefanova NA; Muraleva NA; Korbolina EE; Kiseleva E; Maksimova KY; Kolosova NG
Oncotarget; 2015 Jan; 6(3):1396-413. PubMed ID: 25595891
[TBL] [Abstract][Full Text] [Related]
20. Investigating degeneration of the retina in young and aged tau P301L mice.
Ho WL; Leung Y; Cheng SS; Lok CK; Ho YS; Baum L; Yang X; Chiu K; Chang RC
Life Sci; 2015 Mar; 124():16-23. PubMed ID: 25592136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
